CV-Acs 90 Tablet
Prescription Required
Product introduction
CV-Acs 90 Tablet belongs to a group of medicines called antiplatelet or blood thinners. It reduces the formation of harmful blood clots in blood vessels, which helps to prevent heart attacks or strokes in people with heart disease.
CV-Acs 90 Tablet is also used to treat people with a recent heart attack or severe heart-related chest pain (unstable angina) who have undergone stenting of the heart. It helps to prevent serious heart-related problems like having another heart attack, stroke, or formation of blood clots in stents in such people.
Your doctor will also prescribe aspirin, another antiplatelet medicine, along with this medicine. CV-Acs 90 Tablet may be taken with or without food and should be taken regularly at the same time each day. It is important to keep taking it even if you feel well. If you stop taking this medicine, it may increase your chances of having another heart attack or stroke.
The most common side effects of this medicine are dyspnea (breathlessness) and bleeding. If you cut or injure yourself, it may take longer than usual for the bleeding to stop. Such episodes of bleeding are usually mild and resolve on their own. Mild breathlessness caused by this medicine usually resolves on its own with continued treatment. Let your doctor know if bleeding persists or if the breathlessness worsens or does not go away.
CV-Acs 90 Tablet is not suitable for some people. Do not take it if you are bleeding from anywhere in the body, such as a stomach ulcer or bleeding within the brain. It is also not recommended for people with liver diseases. Before using the medicine, inform your doctor of any such problems.
Uses of CV-Acs Tablet
- Prevention of heart attack and stroke
Benefits of CV-Acs Tablet
In Prevention of heart attack and stroke
CV-Acs 90 Tablet is an antiplatelet medicine or blood thinner. It prevents blood from clotting inside the veins and arteries, helping the blood flow freely around your body and preventing a heart attack or stroke (deep vein thrombosis or pulmonary embolism). To achieve maximum benefits, take this medicine regularly and make appropriate lifestyle changes. It is often prescribed with a low dose of aspirin, which also helps prevent blood from clotting.
Side effects of CV-Acs Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of CV-Acs
- Bleeding
- Breathlessness
How to use CV-Acs Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. CV-Acs 90 Tablet may be taken with or without food, but it is better to take it at a fixed time.
How CV-Acs Tablet works
CV-Acs 90 Tablet is an antiplatelet medication. It works by preventing platelets from sticking together, thereby decreasing the formation of harmful blood clots. This lowers the chance of heart attack or stroke.
Safety advice
Alcohol
CAUTION
Caution is advised when consuming alcohol with CV-Acs 90 Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
CV-Acs 90 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Information regarding the use of CV-Acs 90 Tablet during breastfeeding is not available. Please consult your doctor.
Driving
CONSULT YOUR DOCTOR
It is not known whether CV-Acs 90 Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Dizziness, confusion, vertigo, and syncope have been reported in some patients. If you experience such symptoms, be cautious while driving or using machines.
Dizziness, confusion, vertigo, and syncope have been reported in some patients. If you experience such symptoms, be cautious while driving or using machines.
Kidney
SAFE IF PRESCRIBED
CV-Acs 90 Tablet is safe to use in patients with kidney disease. No dose adjustment of CV-Acs 90 Tablet is recommended.
Limited information is available on the use of CV-Acs 90 Tablet in renal dialysis patients.
Limited information is available on the use of CV-Acs 90 Tablet in renal dialysis patients.
Liver
SAFE IF PRESCRIBED
CV-Acs 90 Tablet is safe to use in patients with liver disease. No dose adjustment of CV-Acs 90 Tablet is recommended.
Use of CV-Acs 90 Tablet is not recommended in patients with severe liver disease.
Use of CV-Acs 90 Tablet is not recommended in patients with severe liver disease.
What if you forget to take CV-Acs Tablet?
If you miss a dose of CV-Acs 90 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
CV-Acs 90 Tablet
₹28.43/Tablet
Brilinta 90mg Tablet
AstraZeneca
₹37/tablet
30% costlier
Axcer 90mg Tablet
Sun Pharmaceutical Industries Ltd
₹30.5/tablet
7% costlier
Brilinta 90mg Tablet
AstraZeneca
₹29.84/tablet
5% costlier
Ticagat Tablet
Natco Pharma Ltd
₹17.57/tablet
38% cheaper
Ticabest Tablet
Zuventus Healthcare Ltd
₹29.9/tablet
5% costlier
Quick tips
- For best results, take it at the same time every day.
- CV-Acs 90 Tablet increases your risk of bleeding. Be careful while shaving, using sharp objects, or cutting fingernails or toenails.
- Do not discontinue using the medicine without consulting your doctor, as this may increase your chances of having another heart attack or stroke.
- If you are scheduled to undergo surgery or dental treatment, you may be asked to temporarily stop taking CV-Acs 90 Tablet.
- You may experience shortness of breath in the initial weeks of therapy. Notify your doctor if it becomes worse or persists for long.
Fact Box
Chemical Class
Triazolopyrimidines
Habit Forming
No
Therapeutic Class
BLOOD RELATED
Action Class
P2Y12 inhibitors (ADP receptor)
Patient concerns
FAQs
Q. Is CV-Acs 90 Tablet an anticoagulant?
CV-Acs 90 Tablet is an antiplatelet medicine or blood thinner. It helps blood flow more easily through the blood vessels, reducing the chances of developing dangerous blood clots.
Q. Can I drink alcohol with CV-Acs 90 Tablet?
Drinking too much alcohol while taking CV-Acs 90 Tablet can irritate your stomach. This can increase your risk of getting a stomach ulcer. Therefore, avoid alcohol intake while taking this medicine.
Q. What is the most important thing I should know about CV-Acs 90 Tablet?
CV-Acs 90 Tablet is a blood thinner, which lowers your chance of getting or dying from a heart attack or stroke. However, this blood-thinning property of CV-Acs 90 Tablet (and similar drugs) can cause severe bleeding and may even lead to death in some cases. The need for blood transfusions or surgery may arise in cases of serious bleeding, such as internal bleeding.
Q. What will happen if I stop taking CV-Acs 90 Tablet?
Do not stop taking CV-Acs 90 Tablet without talking to your doctor. Doing this may increase your risk of getting a heart attack or stroke. Moreover, people treated with a stent should continue taking it, as stopping this medicine may increase the risk of getting a blood clot. As a result, the person may become susceptible to a heart attack or even death.
Q. Should I stop taking CV-Acs 90 Tablet before having surgery or dental treatment?
Your doctor may instruct you to stop taking CV-Acs 90 Tablet 5 days before surgery. This will help decrease your risk of excessive bleeding during surgery or procedure. Your doctor will advise you when to start taking CV-Acs 90 Tablet again.
Q. How long does CV-Acs 90 Tablet take to work?
CV-Acs 90 Tablet starts working within 30 minutes of taking your first dose. You may not feel any different after you start taking CV-Acs 90 Tablet, but this does not mean that the medicine is not working. Keep taking this medicine even if you feel well, as you will still be getting its benefits.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 871-72.
- Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 351-52.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1359-60.
- Ticagrelor. Luton, Bedfordshire: AstraZeneca UK Limited; 2010 [revised 15th Nov. 2018]. [Accessed 24 Jan. 2019] (online) Available from:
- Ticagrelor. Wilmington, Delaware: AstraZeneca LP; 2015. [Accessed 20 Mar. 2019] (online) Available from:
- Ticagrelor. Wilmington, Delaware: AstraZeneca LP; 2011 [revised Sep. 2015]. [Accessed 19 Mar. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 19 Mar. 2019] (online) Available from:
- Ticagrelor [Package Insert]. Ahmedabad, Gujarat: Torrent Pharmaceuticals Ltd.; 2020. [Accessed 07 Aug. 2023]. (online) Available from:
- Ticagrelor [Product Monograph]. Mississauga, Ontario: AstraZeneca Canada Inc.; 2024. [Accessed Oct. 10, 2024] (online) Available from:
Marketer details
Name: Physiment Pharmaceutical LLP
Address: Unit No.105, Aradhya One C-Wing,Plot No. 86 & 87, Pestom SagarRoad No.1, Amar Mahal, Chembur (W). Mumbai- 400089
Country of origin: India
The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.
The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.
Lab tests offered by us
Related/Popular tests
₹398
Inclusive of all taxes
MRP₹415 4% OFF
14.0 tablets in 1 strip
SOLD OUT
Notify me
Available options
Available options
Same salt composition:Ticagrelor (90mg)
Same salt composition
Verified by doctors
Popularly bought
Trusted quality
Why buy these from 1mg?
